These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 26611111)

  • 21. Radiofrequency ablation of pulmonary tumors.
    Crocetti L; Lencioni R
    Eur J Radiol; 2010 Jul; 75(1):23-7. PubMed ID: 20452739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unresectable Adrenal Metastases: Clinical Outcomes of Radiofrequency Ablation.
    Hasegawa T; Yamakado K; Nakatsuka A; Uraki J; Yamanaka T; Fujimori M; Miki M; Sasaki T; Sakuma H; Sugimura Y
    Radiology; 2015 Nov; 277(2):584-93. PubMed ID: 25997031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
    Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
    Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients.
    Schneider T; Puderbach M; Kunz J; Bischof A; Giesel FL; Dienemann H; Herth FJ; Schnabel PA; Safi S; Hoffmann H; Heussel CP
    Respiration; 2012; 84(6):501-8. PubMed ID: 23037897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).
    Lencioni R; Crocetti L; Cioni R; Suh R; Glenn D; Regge D; Helmberger T; Gillams AR; Frilling A; Ambrogi M; Bartolozzi C; Mussi A
    Lancet Oncol; 2008 Jul; 9(7):621-8. PubMed ID: 18565793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous radiofrequency ablation for pulmonary metastases from esophageal cancer: retrospective evaluation of 21 patients.
    Matsui Y; Hiraki T; Gobara H; Fujiwara H; Iguchi T; Shirakawa Y; Fujiwara T; Toyooka S; Kanazawa S
    J Vasc Interv Radiol; 2014 Oct; 25(10):1566-72. PubMed ID: 25156828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
    de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
    Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transosseous Route for CT Fluoroscopy-Guided Radiofrequency Ablation of Lung Tumors.
    Iguchi T; Hiraki T; Ishii H; Gobara H; Fujiwara H; Matsui Y; Kanazawa S
    J Vasc Interv Radiol; 2015 Nov; 26(11):1694-8. PubMed ID: 26432461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation of lung metastases from adenoid cystic carcinoma of the head and neck: retrospective evaluation of nine patients.
    Iguchi T; Hiraki T; Gobara H; Fujiwara H; Matsui Y; Toyooka S; Nishizaki K; Kanazawa S
    J Vasc Interv Radiol; 2015 May; 26(5):703-8. PubMed ID: 25655029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Hamamoto S; Toyoshima M; Nakamura K; Miki Y
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):787-93. PubMed ID: 19967367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.
    Suh RD; Wallace AB; Sheehan RE; Heinze SB; Goldin JG
    Radiology; 2003 Dec; 229(3):821-9. PubMed ID: 14657317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers.
    Palussiere J; Lagarde P; Aupérin A; Deschamps F; Chomy F; de Baere T
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):160-6. PubMed ID: 25394595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases.
    Gillams A; Khan Z; Osborn P; Lees W
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):724-30. PubMed ID: 23070108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan.
    Hiraki T; Yamakado K; Ikeda O; Matsuoka T; Kaminou T; Yamagami T; Gobara H; Mimura H; Kawanaka K; Takeda K; Yamashita Y; Inoue Y; Ogawa T; Nishimura T; Kanazawa S
    J Vasc Interv Radiol; 2011 Jun; 22(6):741-8. PubMed ID: 21531575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected].
    Nakamura T; Matsumine A; Yamakado K; Matsubara T; Takaki H; Nakatsuka A; Takeda K; Abo D; Shimizu T; Uchida A
    Cancer; 2009 Aug; 115(16):3774-81. PubMed ID: 19514086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma.
    Kodama H; Yamakado K; Hasegawa T; Takao M; Taguchi O; Fukai I; Sakuma H
    J Vasc Interv Radiol; 2014 Mar; 25(3):333-9. PubMed ID: 24581457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy.
    Schoellnast H; Deodhar A; Hsu M; Moskowitz C; Nehmeh SA; Thornton RH; Sofocleous CT; Alago W; Downey RJ; Azzoli CG; Rosenzweig KE; Solomon SB
    Acta Radiol; 2012 Oct; 53(8):893-9. PubMed ID: 22961644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.